Akoustis Technologies Inc Stock
With 0 Sell predictions and 1 Buy predictions the community sentiment towards the Akoustis Technologies Inc stock is not clear.
With a target price of 28 € there is potential for a 5599900.0% increase which would mean more than doubling the current price of 0.0 € for Akoustis Technologies Inc.
Our community identified positive and negative aspects for Akoustis Technologies Inc stock for the coming years. 1 users see the criterium "EBIT Margin" as a plus for the Akoustis Technologies Inc stock. On the other hand our users think that "Credit Rating" could be a problem in the future.
Pros and Cons of Akoustis Technologies Inc in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Akoustis Technologies Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Akoustis Technologies Inc | - | - | - | - | - | - | - |
| Asure Software | -0.680% | 2.055% | -3.247% | -7.453% | -5.696% | -47.535% | 13.740% |
| Overstock.com | 6.700% | 11.467% | -2.314% | 24.072% | -10.049% | -75.761% | -93.519% |
| Egain Communications | -0.790% | -3.759% | -15.789% | 59.204% | -25.146% | -3.759% | -20.988% |
Comments
Aktis Oncology (AKTS) had its price target raised by HC Wainwright from $30.00 to $33.00. They now have a "buy" rating on the stock.
Show more
Ratings data for AKTS provided by MarketBeat